Cargando…

Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) and Coronavirus disease-2019 (COVID-19), whose etiologic agent is severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), are currently the two deadliest infectious diseases in humans, which together have caused about more than 11 m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aiello, Alessandra, Najafi-Fard, Saeid, Goletti, Delia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470049/ https://www.ncbi.nlm.nih.gov/pubmed/37662901 http://dx.doi.org/10.3389/fimmu.2023.1244556

Ejemplares similares

Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease
por: Petruccioli, Elisa, et al.
Publicado: (2021)

Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection
por: Najafi-Fard, Saeid, et al.
Publicado: (2023)

Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis
por: Booysen, Petro, et al.
Publicado: (2023)

Immunity to the Dual Threat of Silica Exposure and Mycobacterium tuberculosis
por: Konečný, Petr, et al.
Publicado: (2019)

Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis
por: Palucci, Ivana, et al.
Publicado: (2020)

Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection
por: Shah, Taif, et al.
Publicado: (2022)

Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection
por: Petruccioli, Elisa, et al.
Publicado: (2021)

PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease
por: Grassi, Germana, et al.
Publicado: (2021)

Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
por: Grifoni, Alba, et al.
Publicado: (2023)

Immune Responses Following BCG Immunization of Infants in Uganda and United Kingdom Are Similar for Purified Protein Derivative but Differ for Secretory Proteins of Mycobacterium tuberculosis
por: Mawa, Patrice A., et al.
Publicado: (2021)

Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection
por: Shaw, Jane Alexandra, et al.
Publicado: (2023)

Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine
por: Agrati, Chiara, et al.
Publicado: (2022)

Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy
por: Najafi-Fard, Saeid, et al.
Publicado: (2022)

Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy
por: Musso, Maria, et al.
Publicado: (2021)

Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis
por: Farroni, Chiara, et al.
Publicado: (2022)

Human CD4 T-Cells With a Naive Phenotype Produce Multiple Cytokines During Mycobacterium Tuberculosis Infection and Correlate With Active Disease
por: Orlando, Valentina, et al.
Publicado: (2018)

Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination
por: Puro, Vincenzo, et al.
Publicado: (2021)

Reduced maternal immunity and vertical transfer of immunity against SARS-CoV-2 variants of concern with COVID-19 exposure or initial vaccination in pregnancy
por: Boelig, Rupsa C., et al.
Publicado: (2023)

ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients
por: Picchianti-Diamanti, Andrea, et al.
Publicado: (2021)

Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review
por: Cantini, Fabrizio, et al.
Publicado: (2020)

Editorial: Host immune evasion by Mycobacterium tuberculosis: Current updates
por: Habtamu, Meseret, et al.
Publicado: (2022)

Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
por: Aiello, Alessandra, et al.
Publicado: (2021)

Modeling the Mycobacterium tuberculosis Granuloma – the Critical Battlefield in Host Immunity and Disease
por: Guirado, Evelyn, et al.
Publicado: (2013)

Lung Tissue Resident Memory T-Cells in the Immune Response to Mycobacterium tuberculosis
por: Ogongo, Paul, et al.
Publicado: (2019)

Immune regulation and emerging roles of noncoding RNAs in Mycobacterium tuberculosis infection
por: Liang, Shufan, et al.
Publicado: (2022)

Infection with hypervirulent Mycobacterium tuberculosis triggers emergency myelopoiesis but not trained immunity
por: Maceiras, Ana Raquel, et al.
Publicado: (2023)

Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection
por: Chiacchio, Teresa, et al.
Publicado: (2017)

Co-infection of mice with SARS-CoV-2 and Mycobacterium tuberculosis limits early viral replication but does not affect mycobacterial loads
por: Baker, Paul J., et al.
Publicado: (2023)

It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity
por: Larsen, Sasha E., et al.
Publicado: (2022)

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
por: Søraas, Arne, et al.
Publicado: (2022)

Cell-Mediated Immune Responses to in vivo-Expressed and Stage-Specific Mycobacterium tuberculosis Antigens in Latent and Active Tuberculosis Across Different Age Groups
por: Coppola, Mariateresa, et al.
Publicado: (2020)

Accuracy of an experimental whole-blood test for detecting reactivation of echinococcal cysts
por: Petrone, Linda, et al.
Publicado: (2021)

A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients
por: Petrone, Linda, et al.
Publicado: (2021)

Erratum: Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
Publicado: (2023)

Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members
por: Jay, Cecilia, et al.
Publicado: (2023)

Similarities and Differences in the Acute-Phase Response to SARS-CoV-2 in Rhesus Macaques and African Green Monkeys
por: Coleman, Celeste, et al.
Publicado: (2021)

Editorial: Causes for Increased Susceptibility to Mycobacterium tuberculosis – A Close View of the Immune System
por: Venketaraman, Vishwanath
Publicado: (2015)

Trying to See the Forest through the Trees: Deciphering the Nature of Memory Immunity to Mycobacterium tuberculosis
por: Orme, Ian M., et al.
Publicado: (2018)

Changes in Mycobacterium tuberculosis-Specific Immunity With Influenza co-infection at Time of TB Diagnosis
por: Mendy, Joseph, et al.
Publicado: (2019)

Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG
por: Diogo, Gil R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f7fevjrfbj7se0qbeqs59kc4b3